Skip to main content

Want a detailed portfolio tracker?

Anavex Life Sciences (AVXL) P/E (2010 - 2026)

Anavex Life Sciences (AVXL) P/E from Sep 30, 2010 to Jul 21, 2026. The TTM Anavex Life Sciences (AVXL) P/E is -5.54. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Anavex Life Sciences (AVXL)

YearP/EChange
2026-5.54-28.23%
2025-7.72-60.47%
2024-19.54+24.21%
2023-15.73+5.35%
2022-14.93-52.71%
2021-31.57+160.19%
2020-12.13+133.82%
2019-5.19+45.95%
2018-3.56-64.73%
2017-10.08+5.30%
2016-9.58+0.40%
2015-9.54+198.54%
2014-3.19-82.22%
2013-17.97+975.73%
2012-1.67-31.52%
2011-2.44-69.68%
2010-8.04N/A

Comparison Anavex Life Sciences (AVXL) P/E with competitors

Anavex Life Sciences (AVXL) P/E is -5.54.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.03%
NBYStablecoin Development Corp0.00-100.08%
ENLVEnlivex Ltd0.07-101.35%
FGENFibroGen Inc0.24-104.33%
CHRSCoherus Biosciences Inc0.85-115.31%
FBIOFortress Biotech Inc0.95-117.12%
ORMPOramed Pharmaceuticals Inc1.50-127.12%
AGENAgenus Inc3.01-154.30%
INVAInnoviva Inc3.15-156.90%
VXRTVaxart Inc3.55-164.04%
CRMDCorMedix Inc3.63-165.46%
CVACCureVac N.V.4.45-180.21%
GLPGGalapagos NV4.86-187.66%
SRPTSarepta Therapeutics Inc4.88-188.08%
ABEOAbeona Therapeutics Inc5.39-197.20%
ABUSArbutus Biopharma Corp5.60-200.95%
ZVRAZevra Therapeutics Inc5.89-206.21%
SPROSpero Therapeutics Inc6.23-212.37%
CGENCompugen Ltd6.31-213.91%
RIGLRigel Pharmaceuticals6.87-223.98%
SLXNSilexion Therapeutics Corp7.30-231.63%
OMEROmeros Corporation9.26-267.04%
AUPHAurinia Pharmaceuticals Inc9.58-272.93%
PLXProtalix BioTherapeutics Inc10.89-296.49%
ACADAcadia Pharmaceuticals Inc11.73-311.60%
TBPHTheravance Biopharma Inc12.26-321.23%
ADMAAdma Biologics Inc12.42-324.04%
HRMYHarmony Biosciences Holdings Inc13.82-349.34%
SABSSAB Biotherapeutics Inc14.14-355.04%
NAGENiagen Bioscience Inc14.82-367.34%
INCYIncyte Corp15.82-385.46%
REGNRegeneron Pharmaceuticals Inc15.86-386.08%
PBYIPuma Biotechnology Inc17.32-412.40%
CPRXCatalyst Pharmaceuticals Inc17.44-414.63%
EXELExelixis Inc17.54-416.41%
TGTXTG Therapeutics Inc18.97-442.18%
MDXGMimedx Group Inc20.55-470.80%
XOMAXOMA Royalty Corp22.87-512.70%
ARGXArgen X SE24.30-538.38%
CTMXCytomX Therapeutics Inc24.82-547.82%
XOMAOXOMA Royalty Corp25.34-557.27%
HALOHalozyme Therapeutics Inc25.62-562.30%
XOMAPXOMA Royalty Corp25.67-563.14%
VRTXVertex Pharmaceuticals Inc27.99-605.08%
RPRXRoyalty Pharma plc - Class A28.69-617.58%
SLNOSoleno Therapeutics Inc29.02-623.49%
ASNDAscendis Pharma A/S30.09-642.80%
LGNDLigand Pharmaceuticals Inc - Class B37.91-784.01%
APLSApellis Pharmaceuticals Inc39.02-804.02%
BMRNBiomarin Pharmaceutical Inc42.21-861.58%
KRYSKrystal Biotech Inc45.34-918.08%
ONCBeiGene Ltd69.54-1354.65%
PHARPharming Group N.V.75.03-1453.61%
TECHBio-Techne Corp101.96-1939.53%
VCELVericel Corp109.92-2083.20%
ALNYAlnylam Pharmaceuticals Inc117.96-2228.32%
GMABGenmab140.29-2631.12%
TLXTelix Pharmaceuticals Ltd162.15-3025.56%
CORTCorcept Therapeutics Inc212.86-3940.37%